B6.Cg-Tg(Thy1-SERPINI1*S49P)680Zbz/Biat

Status

Available to order

EMMA IDEM:10871
Citation informationRRID:IMSR_EM:10871 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameB6.Cg-Tg(Thy1-SERPINI1*S49P)680Zbz/Biat
Alternative nameTg(NS-S49P)680Zbz
Strain typeTransgenic Strains
Allele/Transgene symbolTg(Thy1-SERPINI1*S49P)680Zbz
Gene/Transgene symbolTg(Thy1-SERPINI1*S49P)680Zbz

Information from provider

ProviderThomas Ruelicke
Provider affiliationDepartment 1 (Biomedical Sciences), University of Veterinary Medicine, Vienna
Genetic informationTransgenic mice overexpressing human neuroserpin with the S49P-Syracuse mutation under the control of the Thy1 promoter were generated by pronuclear injection into fertilized oocytes using an expression cassette derived from the murine Thy1 gene. The S49P-Syracuse mutation was introduced into the human neuroserpin cDNA using the polymerase chain reaction technique. The transgene was expressed in central nervous system neurons throughout postnatal life. The expression levels for transgenic mice overexpressing human Syracuse neuroserpin were for transgenic mice with human wild-type neuroserpin 3.4 times above the endogenous neuroserpin level of wild-type mice.
Phenotypic informationHomozygous:
unknown

Heterozygous:
See attached paper "Accumulation of Mutant Neuroserpin Precedes Development of Clinical Symptoms in Familial Encephalopathy with Neuroserpin Inclusion Bodies"
Breeding historyThe transgenic lines were generated on a B6D2F2 hybrid background and backcrossed to C57BL/6J for at least 10 generations.
References
  • Accumulation of mutant neuroserpin precedes development of clinical symptoms in familial encephalopathy with neuroserpin inclusion bodies.;Galliciotti Giovanna, Glatzel Markus, Kinter Jochen, Kozlov Serguei V, Cinelli Paolo, Rülicke Thomas, Sonderegger Peter, ;2007;The American journal of pathology;170;1305-13; 17392169
Homozygous fertilenot known
Homozygous viablenot known
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreUniversity of Veterinary Medicine, Vienna, Austria
Animals used for archivingheterozygous C57BL/6J males

Literature references

  • Accumulation of mutant neuroserpin precedes development of clinical symptoms in familial encephalopathy with neuroserpin inclusion bodies.;Galliciotti Giovanna, Glatzel Markus, Kinter Jochen, Kozlov Serguei V, Cinelli Paolo, Rülicke Thomas, Sonderegger Peter, ;2007;The American journal of pathology;170;1305-13; 17392169

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).